MedPath

study on comparing drug response of bupivacaine with dexmedetomidine and levobupivacaine with dexmedetomidine(drug name)in spinal anaesthesia for lower limb surgeries-A Randomised Controlled trial

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: - Health Condition 2: G00-G99- Diseases of the nervous system
Registration Number
CTRI/2023/02/049787
Lead Sponsor
Chowndharrya Soccalingame
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 18to60yrs

American society of anaesthesiologists class 1 and 2

Patient undergoing elective infraumbilical surgeries

Exclusion Criteria

Contraindications for neuraxial blockade

Patient converted to general anaesthesia

Any psychiatric illness or on antipsychotic medications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
O.5%levobupivacaine with 50mcg dexmedetomidine will show onset and prolonged duration of sensory and motor blockade than 0.5%bupivacaine with dexmedetomidine in subarachnoid BlockTimepoint: Sensory blockade will be assessed by 3point qualitative scale,motor blockade assessed by 3point qualitative scale, Post operative pain assessed by visual analogue scale at 0min,3min,6min,9min,12min,15min,30min,45min,60min,90min,120min,6hrs,12hrs,24hrs
Secondary Outcome Measures
NameTimeMethod
O.5%bupivacaine with 50mcg dexmedetomidine will show lesser onset and duration of sensory and motor blockade than 0.5%levobupivacaine with 50mcg dexmedetomidine in subarachnoid blockTimepoint: Sensory blockade will be assessed by 3point qualitative scale,motor blockade assessed by 3point qualitative scale, Post operative pain assessed by visual analogue scale at 0min,3min,6min,9min,12min,15min,30min,45min,60min,90min,120min,6hrs,12hrs,24hrs
© Copyright 2025. All Rights Reserved by MedPath